MediaOutreach.com English

Angsana’s RNA-based fusions cancer panel selected for Ignyta’s STARTRK2 clinical trial in Asia-Pacific

Author: Business News

SINGAPORE - Media OutReach - Mar 3, 2017 - Angsana Molecular & Diagnostics has announced today that it will be a partner molecular test laboratory for STARTRK-2 clinical trial sites in Asia working with Ignyta, Inc., (NASDAQ: RXDX), a biotechnology company focused on precision medicine in oncology. Angsana Molecular & Diagnostics'...

More...

More Articles...

Electrolux strengthens professional offering with beverage products by acquiring Grindmaster-Cecilware
Correction: CDNetworks Integrates Web Performance and Security for Media and E-Commerce Industry
Asian Transport Industry Sees Digital Vulnerability as No. 1 Risk - Willis Towers Watson Study
Annual Alcatel-Lucent Enterprise APAC Partner Event Celebrates 2016 Partner Achievements
PSB Academy recognized for Outstanding Corporate Reputation Programme
Puratos opens Asia Development Centre in Hong Kong to help local bakery sector better serve Asia’s changing tastes
Vpon Releases the Latest APAC Mobile Programmatic Advertising Statistics and Trends Report
Trend Micro 2016 Security Roundup Reveals 752 Percent Increase in Ransomware
CITIC-Prudential Life Insurance Receives Regulatory Approval To Establish A Branch In China’s Sichuan Province
Newly formed enterprise collaboration drives Ethereum blockchain technology best practices focusing on security, privacy, scalability, and interoperability

Page 3846 of 4985